NueCell Bio Launches GMP Cell Therapy Development Platform
San Diego, California, August 5, 2026 NueCell Bio has officially launched as a specialized cell therapy science and development...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
San Diego, California, August 5, 2026 NueCell Bio has officially launched as a specialized cell therapy science and development...
LUND, Sweden, June 22, 2026 Hamlet BioPharma AB has announced a significant expansion of its U.S. clinical development program...
SHANGHAI, China, June 3, 2026 Antengene has announced the first preclinical data for ATG-207, its investigational αCD3-TGF-β bifunctional fusion...
DURHAM, N.C. and BEIJING, China, May 27, 2026 Brii Biosciences Limited (Brii Bio) has presented new late-breaking clinical and...
WILMINGTON, Del. & SAN MATEO, Calif., May 20, 2026 Incyte and Genesis Molecular AI have announced a significant expansion...
PARIS and CAMBRIDGE, UK, May 13, 2026 AndzonBio2 announced a strategic collaboration with the ALBORADA Drug Discovery Institute (ADDI)...
ENCINITAS, Calif., May 11, 2026 Vasa Therapeutics, a clinical-stage biotechnology company focused on therapies targeting cardiovascular and metabolic aging,...
STRATFORD, Conn., May 8, 2026 KUBTEC Scientific has launched the XCELL® TomoRad™ x-ray irradiator, a next-generation image-guided radiotherapy (IGRT)...
HYDERABAD, India, Feb. 16, 2026 — The University of Hyderabad and MNJ Institute of Oncology & Regional Cancer Centre...
Lille & Paris, France — February 10, 2026: 4Moving Biotech (4MB), a clinical-stage biotechnology company and spin-off of 4P-Pharma,...
